The judgment was to permit Par to market its generic formulation of Ultram ER in the US, on condition that it receive final regulatory approval from the ...
... attempt to manufacture and market the generic version of the analgesic tramadol ER (brandname-Ultram ER) infringes patent coverage of the innovator. ...
... reliever used to treat moderate to severe chronic pain, according to the drugs.com Web site. The drug also is sold under brand names Ultram and Ultram ER.
... an ANDA to manufacture a generic version of plaintiffs' Ultram® ER (tramadol hydrochloride, used to treat moderate to moderately severe chronic pain). ...
